Literature DB >> 23576813

For whom the bell tolls: isoniazid preventive therapy and tuberculosis drug resistance.

Frank G J Cobelens1.   

Abstract

The expected increase in drug-resistant tuberculosis due to large-scale preventive treatment in people living with HIV calls for reconsidering the "double use" of isoniazid for prophylaxis and curative treatment (Mills et al., this issue).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23576813     DOI： 10.1126/scitranslmed.3006094

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  3 in total

Review 1.  Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons.

Authors:  Christopher Akolo; Florence Bada; Evaezi Okpokoro; Ogochukwu Nwanne; Sharon Iziduh; Eno Usoroh; Taofeekat Ali; Vivian Ibeziako; Olanrewaju Oladimeji; Michael Odo
Journal:  World J Virol       Date:  2015-05-12

2.  The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population.

Authors:  Hyo-Jin Lee; Dong-Gun Lee; Su-Mi Choi; Sun Hee Park; Sung-Yeon Cho; Jae-Ki Choi; Si-Hyun Kim; Jung-Hyun Choi; Jin-Hong Yoo; Byung-Sik Cho; Ki-Seong Eom; Seok Lee; Yoo-Jin Kim; Hee-Je Kim; Chang-Ki Min; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Jung Im Jung
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

3.  Therapeutic effect of minimally invasive catheter drainage and local chemotherapy for the lumbosacral tuberculosis without neural symptoms.

Authors:  Tian-Qing Li; Zhen-Sheng Ma; Yang Zhang; Hui-Fa Xu; Wei Lei
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.